Fairfield, Bush & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,900
| Closed | -$338K | – | 150 |
|
|
2023
Q2 | $338K | Buy |
+3,900
| New | +$338K | 0.09% | 121 |
|
|
2020
Q3 | – | Sell |
-2,000
| Closed | -$247K | – | 146 |
|
|
2020
Q2 | $247K | Buy |
+2,000
| New | +$247K | 0.09% | 126 |
|
|
2016
Q1 | – | Sell |
-2,791
| Closed | -$292K | – | 137 |
|
|
2015
Q4 | $292K | Buy |
+2,791
| New | +$292K | 0.1% | 115 |
|
|
2015
Q3 | – | Sell |
-1,996
| Closed | -$273K | – | 142 |
|
|
2015
Q2 | $273K | Sell |
1,996
-214
| -10% | -$29.3K | 0.08% | 143 |
|
|
2015
Q1 | $275K | Sell |
2,210
-910
| -29% | -$113K | 0.08% | 142 |
|
|
2014
Q4 | $282K | Hold |
3,120
| – | – | 0.08% | 144 |
|
|
2014
Q3 | $225K | Buy |
+3,120
| New | +$225K | 0.06% | 160 |
|